The invention identifies PD-1 as a receptor for B7-4. B7-4 can inhibit immune cell activation upon binding to an inhibitory receptor on an immune cell. Accordingly, the invention provides agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response.

 
Web www.patentalert.com

< Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments

< Plasmin variants and uses thereof

> Protein HDPBQ71

> Solutions and aerosols of metal-containing compounds

~ 00294